Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-08-31A Phase I Trial Testing Multiple Antigen-Engineered DC Followed by IFNa2b Boost for Immunization of HLA-Unrestricted Melanoma Patients
-
CLINICAL_TRIALS study record update · 2017-08-17A Phase I Trial Of The Humanized Anti-GD2 Antibody (HU14.18K322A) In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma
-
CLINICAL_TRIALS study record update · 2017-08-17A Phase 1 Open Label, Multicenter, Multiple Ascending Dose Trial Evaluating the Safety, Tolerability and Immunogenicity of Intramuscular Recombinant NY-ESO-1 Protein With GLA-SE Adjuvant in Patients With Unresectable or Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2017-08-15An Open Label Non Randomized Access Study of Trametinib for Patients With Advanced Unresectable (Stage IIIc) or Distant Metastatic (Stage IV) BRAF V600E/K Mutation Positive Cutaneous Melanoma
-
CLINICAL_TRIALS study record update · 2017-08-04Pilot Analysis of the Effects of IFN α2b Upon the Molecular Profile of Regional Lymph Nodes in Melanoma Patients With and Without Tumor-Involved Sentinel Lymph Nodes
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-07-27A Phase II Study of IL-18 in Melanoma Patients
-
CLINICAL_TRIALS study record update · 2017-07-26Culture and Characterization of Circulating Tumor Cells (CTC) From Patients With Malignant Melanoma and Other Cancers
-
CLINICAL_TRIALS study record update · 2017-07-24A Phase 2 Trial of the BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 Mutation
-
CLINICAL_TRIALS study record update · 2017-07-21Phase I Study of Cellular Adoptive Immunotherapy Using Autologous CD4+ NY-ESO-1-Specific T Cells and Anti-CTLA4 For Patients With NY-ESO-1-Expressing Tumors
-
CLINICAL_TRIALS study record update · 2017-07-21A Phase I/II Open-Label Study TPI 287 in Combination With Temozolomide in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2017-07-02Genetic Analysis of Familial Melanoma
-
CLINICAL_TRIALS study record update · 2017-07-02Microarray Analysis for Human Genetic Disease
-
CLINICAL_TRIALS study record update · 2017-07-02Randomized Phase II Neoadjuvant Study of Temozolomide Alone or With Pegylated Interferon-alpha 2b in Patients With Resectable American Joint Committee on Cancer (AJCC) Stage IIIB/IIIC or Stage IV (M1a) Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2017-06-23Randomized Phase II Trial of Vemurafenib (PLX4032/RG7204)/Cobimetinib (GDC-0973) With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma
-
CLINICAL_TRIALS study record update · 2017-06-23A Phase II Study of the Clinical and Immunological Effects of NY-ESO-1 ISCOM® Vaccine in Patients With Measurable Stage III and IV Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2017-06-12Vaccination of Patients With Stage IV Melanoma With Dendritic Cells Generated Ex Vivo From Monocytes and Loaded With Heat Treated Killed Allogeneic Melanoma Cells
-
CLINICAL_TRIALS study record update · 2017-06-07Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR
-
CLINICAL_TRIALS study record update · 2017-06-06Infrared Lymphangiography as a Method of Sentinel Node Identification
-
CLINICAL_TRIALS study record update · 2017-06-01TIL (Tumor Infiltrating Lymphocytes) and IL2 (Interleukin 2) Versus Abstention as Adjuvant Treatment in Melanoma With Only One Invaded Lymphnode After Lymphnodes Excision
-
CLINICAL_TRIALS study record update · 2017-05-31IPI-Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2017-05-30Melanomas Excised in Primary Care vs Secondary Care Excision
-
CLINICAL_TRIALS study record update · 2017-05-09A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma
-
CLINICAL_TRIALS study record update · 2017-05-09Multicenter Phase 2 Evaluation of Temozolomide for Treatment of Brain Metastases of Either Malignant Melanoma, Breast and Non-small Cell Lung Cancer.
-
CLINICAL_TRIALS study record update · 2017-05-03A Prospective, Non-controlled, Multicenter Clinical Study to Evaluate the Diagnostic Accuracy of the Stepwise Two Photon Excited Melanin Fluorescence of Potentially Malignant Pigmented Lesions as Compared to Histopathological Diagnosis
-
CLINICAL_TRIALS study record update · 2017-05-03Randomized, Multicenter, Open Label Study to Compare the Efficacy and Tolerability of Pegylated Interferon-alpha-2 (PEG-IFN) to 'Low-dose' Interferon-alpha-2a in Patients With Malignant Melanoma in Stages IIA (T3a) - IIIB (AJCC 2002)